Annual Accounts Payable
$391.31 M
+$172.43 M+78.78%
31 December 2023
Summary:
BioNTech SE annual accounts payable is currently $391.31 million, with the most recent change of +$172.43 million (+78.78%) on 31 December 2023. During the last 3 years, it has risen by +$265.49 million (+211.00%). BNTX annual accounts payable is now at all-time high.BNTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$851.75 M
-$93.13 M-9.86%
01 September 2024
Summary:
BioNTech SE quarterly accounts payable is currently $851.75 million, with the most recent change of -$93.13 million (-9.86%) on 01 September 2024. Over the past year, it has increased by +$616.02 million (+261.33%). BNTX quarterly accounts payable is now -9.86% below its all-time high of $944.88 million, reached on 30 June 2024.BNTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.8% | +261.3% |
| 3 y3 years | +211.0% | +183.6% |
| 5 y5 years | +719.9% | +3468.9% |
BNTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +211.0% | -9.9% | +2512.4% |
| 5 y | 5 years | at high | +1604.2% | -9.9% | +3877.2% |
| alltime | all time | at high | +5853.0% | -9.9% | +4337.6% |
BioNTech SE Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $851.75 M(-9.9%) |
| June 2024 | - | $944.88 M(+192.8%) |
| Mar 2024 | - | $322.67 M(-17.5%) |
| Dec 2023 | $391.31 M(+78.8%) | $391.31 M(+66.0%) |
| Sept 2023 | - | $235.73 M(-5.1%) |
| June 2023 | - | $248.43 M(+662.0%) |
| Mar 2023 | - | $32.60 M(-85.1%) |
| Dec 2022 | $218.88 M(+20.8%) | $218.88 M(-24.9%) |
| Sept 2022 | - | $291.43 M(-4.2%) |
| June 2022 | - | $304.08 M(+120.2%) |
| Mar 2022 | - | $138.06 M(-23.8%) |
| Dec 2021 | $181.16 M | $181.16 M(-39.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $300.30 M(-3.9%) |
| June 2021 | - | $312.62 M(+151.1%) |
| Mar 2021 | - | $124.50 M(-1.1%) |
| Dec 2020 | $125.82 M(+448.0%) | $125.82 M(+155.7%) |
| Sept 2020 | - | $49.21 M(+22.6%) |
| June 2020 | - | $40.14 M(+87.4%) |
| Mar 2020 | - | $21.42 M(-6.7%) |
| Dec 2019 | $22.96 M(-51.9%) | $22.96 M(-3.8%) |
| Sept 2019 | - | $23.87 M(+24.3%) |
| June 2019 | - | $19.19 M(-59.8%) |
| Dec 2018 | $47.72 M(-24.3%) | $47.72 M |
| Dec 2017 | $63.03 M(+858.9%) | - |
| Dec 2016 | $6.57 M | - |
FAQ
- What is BioNTech SE annual accounts payable?
- What is the all time high annual accounts payable for BioNTech SE?
- What is BioNTech SE annual accounts payable year-on-year change?
- What is BioNTech SE quarterly accounts payable?
- What is the all time high quarterly accounts payable for BioNTech SE?
- What is BioNTech SE quarterly accounts payable year-on-year change?
What is BioNTech SE annual accounts payable?
The current annual accounts payable of BNTX is $391.31 M
What is the all time high annual accounts payable for BioNTech SE?
BioNTech SE all-time high annual accounts payable is $391.31 M
What is BioNTech SE annual accounts payable year-on-year change?
Over the past year, BNTX annual accounts payable has changed by +$172.43 M (+78.78%)
What is BioNTech SE quarterly accounts payable?
The current quarterly accounts payable of BNTX is $851.75 M
What is the all time high quarterly accounts payable for BioNTech SE?
BioNTech SE all-time high quarterly accounts payable is $944.88 M
What is BioNTech SE quarterly accounts payable year-on-year change?
Over the past year, BNTX quarterly accounts payable has changed by +$616.02 M (+261.33%)